Astromech CEO Ben Lamm (Courtesy of Astromech)
Astromech, a startup spun out of Colossal Biosciences that predicts biological outcomes using AI, has nearly doubled its valuation in four months.
Why it matters: That comes as Colossal, also helmed by CEO Ben Lamm, is similarly seeking to swell its valuation.
